The Importance of the Proof-of-Concept Stage while Producing a Glioblastoma Multiform Drug Candidate Video

Published on: 

Learn how TargTex partners with Nanoform to produce therapies for Glioblastoma patients. This process includes identifying novel targets with small molecules, utilizing Nanoform technology to increase the active pharmaceutical ingredient [API] concentration, and improving treatment stability to move the drug to clinical development.